Positive impactSector
10 pharma mutual funds delivered over 20% in one year: HDFC Pharma leads with 28.66% return
Mint 1 hr ago·2 Sept 2026, 8:18 am
Ten pharma and healthcare mutual funds have delivered strong returns, with the HDFC Pharma And Healthcare Fund leading the pack at 28.66% over the past year. This performance highlights the sector's resilience and growth potential, even amid broader market volatility. The top performers include Kotak Healthcare, PGIM India Healthcare, and Quant Healthcare, which also saw returns exceeding 20%.
For investors, this trend underscores the importance of diversification within the healthcare sector. While individual stock selection can be rewarding, mutual funds offer a balanced approach by spreading risk across multiple companies. The consistent gains suggest that healthcare remains a stable and attractive investment avenue, particularly for long-term goals.
Moving forward, investors should keep an eye on regulatory changes, drug pricing policies, and global healthcare trends. These factors can significantly impact the sector's performance. Monitoring fund manager strategies and portfolio allocations will also help in understanding how these funds are navigating market dynamics.
Excerpt from Mint
Ten pharma and healthcare mutual funds delivered more than 20% returns in the past year, with HDFC Pharma And Healthcare Fund leading at 28.66%. Kotak Healthcare, PGIM India Healthcare and Quant Healthcare were among the other top performers. Pharma and healthcare mutual funds have had a strong run over the past year,…Read the original at Mint
Key takeaways
- Category: Sector.
- AI reads the tone as positive (potentially bullish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
